The role of cis dimerization of signal regulatory protein alpha (SIRPalpha) in binding to CD47.
Interaction of SIRPα with its ligand, CD47, regulates leukocyte functions, including transmigration, phagocytosis, oxidative burst, and cytokine secretion. Recent progress has provided significant insights into the structural details of the distal IgV domain (D1) of SIRPα. However, the structural roles of proximal IgC domains (D2 and D3) have been largely unstudied. The high degree of conservation of D2 and D3 among members of the SIRP family as well as the propensity of known IgC domains to assemble in cis has led others to hypothesize that SIRPα forms higher order structures on the cell surface. Here we report that SIRPα forms noncovalently linked cis homodimers. Treatment of SIRPα-expressing cells with a membrane-impermeable cross-linker resulted in the formation of SDS-stable SIRPα dimers and oligomers. Biochemical analyses of soluble recombinant extracellular regions of SIRPα, including domain truncation mutants, revealed that each of the three extracellular immunoglobulin loops of SIRPα formed dimers in solution. Co-immunoprecipitation experiments using cells transfected with different affinity-tagged SIRPα molecules revealed that SIRPα forms cis dimers. Interestingly, in cells treated with tunicamycin, SIRPα dimerization but not CD47 binding was inhibited, suggesting that a SIRPα dimer is probably bivalent. Last, we demonstrate robust dimerization of SIRPa in adherent, stimulated human neutrophils. Collectively, these data are consistent with SIRPα being expressed on the cell surface as a functional cis-linked dimer.
Lee
Winston Y
WY
Epithelial Pathobiology Unit, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Weber
Dominique A
DA
Laur
Oskar
O
Stowell
Sean R
SR
McCall
Ingrid
I
Andargachew
Rakieb
R
Cummings
Richard D
RD
Parkos
Charles A
CA
D000818:Animals; D000943:Antigens, Differentiation / Q000235:genetics / Q000378:metabolism*; D051928:CD47 Antigen / Q000235:genetics / Q000378:metabolism*; D016466:CHO Cells; D002448:Cell Adhesion / Q000502:physiology; D006224:Cricetinae; D003412:Cricetulus; D057809:HEK293 Cells; D018922:HL-60 Cells; D006801:Humans; D009154:Mutation; D018375:Neutrophil Activation / Q000502:physiology; D009504:Neutrophils / Q000378:metabolism*; D011485:Protein Binding / Q000502:physiology; D055503:Protein Multimerization / Q000502:physiology*; D017434:Protein Structure, Tertiary; D011971:Receptors, Immunologic / Q000235:genetics / Q000378:metabolism*; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism
D000943:Antigens, Differentiation; D051928:CD47 Antigen; C497894:CD47 protein, human; D011971:Receptors, Immunologic; D011994:Recombinant Proteins; C501920:SIRPA protein, human
J Exp Med. 2007 Oct 29;204(11):2719-31
17954568
J Immunol. 2005 Dec 15;175(12):7781-7
16339510
J Biol Chem. 1979 Jul 25;254(14):6572-6
447736
Blood. 2006 Jan 1;107(1):341-8
16141346
Genes Cells. 2008 Feb;13(2):209-19
18233962
J Biol Chem. 2005 Oct 28;280(43):36132-40
16081415
J Cell Biol. 2008 Mar 10;180(5):989-1003
18332220
Science. 1995 Sep 1;269(5228):1273-8
7544493
J Cell Biol. 1996 Feb;132(3):437-50
8636220
Annu Rev Immunol. 1988;6:555-80
2454644
Blood. 2006 Mar 15;107(6):2548-56
16291597
J Biol Chem. 2007 May 11;282(19):14567-75
17369261
Mol Cell. 2008 Jul 25;31(2):266-77
18657508
J Biol Chem. 1997 Jan 31;272(5):3117-23
9006964
J Immunol. 2007 Dec 1;179(11):7741-50
18025220
J Biol Chem. 2004 Apr 2;279(14):13711-20
14739297
J Biol Chem. 2004 Jul 2;279(27):27878-87
15123722
J Biol Chem. 1982 Nov 25;257(22):13421-7
6216250
Eur J Immunol. 2000 Aug;30(8):2130-7
10940903
J Immunol. 2002 Jun 1;168(11):5832-9
12023387
Science. 2000 Jun 16;288(5473):2051-4
10856220
Nat Immunol. 2007 Dec;8(12):1313-23
17982459
Nat Rev Immunol. 2006 Jun;6(6):457-64
16691243
J Biol Chem. 1998 Dec 11;273(50):33423-8
9837919
Eur J Immunol. 2000 Aug;30(8):2147-56
10940905
J Biol Chem. 2005 Feb 18;280(7):5854-61
15545280
J Cell Biol. 1987 Dec;105(6 Pt 1):2665-74
3121636
Nat Rev Immunol. 2002 Feb;2(2):116-26
11910893
Nature. 1997 Mar 13;386(6621):181-6
9062191
J Biol Chem. 1990 Sep 15;265(26):15599-605
2144287
J Mol Biol. 1985 Dec 5;186(3):651-63
4093982
J Biol Chem. 2007 Jan 19;282(3):1805-18
17098740
J Biol Chem. 2000 Jul 14;275(28):21539-48
10779515
Methods Enzymol. 2000;327:198-210
11044984
Mol Biol Cell. 2005 Jul;16(7):3353-64
15888547
Immunity. 2008 Mar;28(3):414-24
18342010
Mol Immunol. 2008 Nov;46(1):97-105
18692901
Cell. 2003 Oct 3;115(1):13-23
14531999
J Mol Biol. 2008 Jan 18;375(3):650-60
18045614
Diabetes. 2008 Oct;57(10):2637-43
18633106
J Biol Chem. 2001 Oct 26;276(43):40156-66
11479293
J Biol Chem. 2002 Mar 22;277(12):10028-36
11792697
J Immunol. 2000 Jan 1;164(1):9-12
10604985
Nucleic Acids Res. 2008 Jan;36(Database issue):D281-8
18039703
Trends Cell Biol. 2001 Mar;11(3):130-5
11306274
J Biol Chem. 2008 Jul 18;283(29):20547-59
18456665
Mol Immunol. 1994 Feb;31(3):169-217
8114766
Science. 1996 Nov 1;274(5288):795-8
8864123
Cell. 2005 Oct 21;123(2):321-34
16239148
J Exp Med. 2001 Apr 2;193(7):855-62
11283158
Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5062-6
17360380
Methods Mol Biol. 2006;341:205-15
16799201
Blood. 2003 Oct 1;102(7):2532-40
12805067
Nature. 2001 Feb 8;409(6821):733-9
11217864
J Immunol. 2004 Aug 15;173(4):2562-70
15294972
J Biol Chem. 2002 Mar 15;277(11):8955-60
11779860
Biochem J. 2001 Dec 15;360(Pt 3):645-9
11736655
Mol Immunol. 2008 Jun;45(11):3025-35
18471880
Blood. 1998 Dec 15;92(12):4602-11
9845526
J Biol Chem. 2008 Dec 5;283(49):34053-61
18819922
Blood. 2008 Aug 15;112(4):1280-9
18524990
J Biol Chem. 2009 Sep 25;284(39):26613-9
19628875
Blood. 2001 May 1;97(9):2741-9
11313266